These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12208796)

  • 1. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
    Stone AF; Mendall MA; Kaski JC; Edger TM; Risley P; Poloniecki J; Camm AJ; Northfield TC
    Circulation; 2002 Sep; 106(10):1219-23. PubMed ID: 12208796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction.
    Choussat R; Montalescot G; Collet J; Jardel C; Ankri A; Fillet A; Thomas D; Raymond J; Bastard J; Drobinski G; Orfila J; Agut H; Thomas D
    Am J Cardiol; 2000 Aug; 86(4):379-84. PubMed ID: 10946028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of short-term treatment with azithromycin on recurrent ischaemic events in patients with acute coronary syndrome in the Azithromycin in Acute Coronary Syndrome (AZACS) trial: a randomised controlled trial.
    Cercek B; Shah PK; Noc M; Zahger D; Zeymer U; Matetzky S; Maurer G; Mahrer P;
    Lancet; 2003 Mar; 361(9360):809-13. PubMed ID: 12642046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a brief course of azithromycin on soluble cell adhesion molecules and markers of inflammation in survivors of an acute coronary syndrome: A double-blind, randomized, placebo-controlled study.
    Hillis GS; Pearson CV; Harding SA; Sutherland S; Ludlam CA; Marioni JC; Prescott RJ; Fox KA; Flapan AD
    Am Heart J; 2004 Jul; 148(1):72-9. PubMed ID: 15215794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chlamydia pneumoniae and Helicobacter pylori infections in acute myocardial infarction].
    Di Tano G; Picerno I; Calisto ML; Delia SA; Lagana P; Spataro P
    Ital Heart J Suppl; 2000 Dec; 1(12):1576-81. PubMed ID: 11221586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome.
    Cannon CP; Braunwald E; McCabe CH; Grayston JT; Muhlestein B; Giugliano RP; Cairns R; Skene AM;
    N Engl J Med; 2005 Apr; 352(16):1646-54. PubMed ID: 15843667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.
    Altannavch Ts; Roubalová K; Broz J; Hrubá D; Andĕl M
    Cent Eur J Public Health; 2003 Jun; 11(2):102-6. PubMed ID: 12884557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial.
    O'Connor CM; Dunne MW; Pfeffer MA; Muhlestein JB; Yao L; Gupta S; Benner RJ; Fisher MR; Cook TD;
    JAMA; 2003 Sep; 290(11):1459-66. PubMed ID: 13129985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rovamycine as add-on treatment in unstable angina and 4 year evolution with major cardiovascular events.
    Rădoi M; Bobescu E; Agache I
    Rom J Intern Med; 2003; 41(3):237-46. PubMed ID: 15526507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) study.
    Anderson JL; Muhlestein JB; Carlquist J; Allen A; Trehan S; Nielson C; Hall S; Brady J; Egger M; Horne B; Lim T
    Circulation; 1999 Mar; 99(12):1540-7. PubMed ID: 10096928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro hyperreactivity to lipopolysaccharide in patients with history of unstable angina is not associated with seropositivity for Cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae.
    Colizzi C; Rizzello V; Angiolillo DJ; Liuzzo G; Ginnetti F; Monaco C; Comerci G; Vitrella G; Maseri A; Biasucci LM
    Cardiologia; 1999 Apr; 44(4):377-80. PubMed ID: 10371790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample.
    Sarrafzadegan N; Rezaporian P; Kaypour M; Mohseni M; Sadeghi M; Asgary S; Sabet B
    East Mediterr Health J; 2008; 14(6):1246-56. PubMed ID: 19161100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial.
    Leowattana W; Bhuripanyo K; Singhaviranon L; Akaniroj S; Mahanonda N; Samranthin M; Pokum S
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S669-75. PubMed ID: 12002908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inflammation and infection in stable coronary disease and acute coronary syndrome].
    Bermejo García J; Martínez Martínez P; Martín Rodríguez JF; de la Torre Carpente M; Bustamante Bustamante R; Guerrero Peral AB; Ortiz de Lejarazu R; Eiros Bouza JM; Blanco García S; Fernández-Avilés F
    Rev Esp Cardiol; 2001 Apr; 54(4):453-9. PubMed ID: 11282050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage].
    el-Rabadi K; Gottsauner-Wolf M; Christ G; Maurer G; Huber K
    Wien Klin Wochenschr; 2001 Oct; 113(19):727-30. PubMed ID: 11715750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS).
    Chandra HR; Choudhary N; O'Neill C; Boura J; Timmis GC; O'Neill WW
    Am J Cardiol; 2001 Aug; 88(3):214-8. PubMed ID: 11472696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial.
    Burkhardt U; Zahn R; Höffler U; Siegler KE; Frilling B; Weber M; Gottwik M; Wehr M; Seidel F; Rosocha S; Tebbe U; Senges J
    Z Kardiol; 2004 Sep; 93(9):671-8. PubMed ID: 15365734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.
    Muhlestein JB; Anderson JL; Carlquist JF; Salunkhe K; Horne BD; Pearson RR; Bunch TJ; Allen A; Trehan S; Nielson C
    Circulation; 2000 Oct; 102(15):1755-60. PubMed ID: 11023928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors.
    Patel P; Mendall MA; Carrington D; Strachan DP; Leatham E; Molineaux N; Levy J; Blakeston C; Seymour CA; Camm AJ
    BMJ; 1995 Sep; 311(7007):711-4. PubMed ID: 7549683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
    Al-Ghamdi A; Jiman-Fatani AA; El-Banna H
    Pak J Pharm Sci; 2011 Apr; 24(2):95-101. PubMed ID: 21454155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.